Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | CYP4F2 | P78329 | 2/20 | 0.33 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | MMP8 | P22894 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | PKM | P14618 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18759662 | 0.84 | CYP4F2 (0.40) | MEN1KMT2AALDH1A1CYP4F2CYP4A11 | |
| SCHEMBL16048 | 0.84 | CYP4F2 (0.40) | MEN1KMT2AALDH1A1CYP4F2CYP4A11 | |
| SCHEMBL413276 | 0.82 | CYP4F2 (0.39) | MEN1KMT2AALDH1A1CYP4F2CYP4A11 | |
| SCHEMBL19278938 | 0.82 | CYP4F2 (0.39) | MEN1KMT2AALDH1A1CYP4F2CYP4A11 | |
| SCHEMBL651926 | 0.77 | FDPS (0.44) | MEN1KMT2AALDH1A1CYP4F2CYP4A11 | |
| SCHEMBL9064918 | 0.75 | MMP8 (0.50) | MEN1KMT2AALDH1A1CYP4F2CYP4A11 | |
| SCHEMBL8171534 | 0.75 | PIN1 (0.39) | MEN1KMT2AALDH1A1CYP4F2CYP4A11 | |
| SCHEMBL2237636 | 0.75 | FDPS (0.43) | MEN1KMT2ACYP4F2CYP4A11PKM | |
| SCHEMBL2392569 | 0.73 | CYP4F2 (0.33) | MEN1KMT2AALDH1A1CYP4F2CYP4A11 | |
| SCHEMBL22446015 | 0.73 | MMP8 (0.38) | MEN1KMT2AALDH1A1CYP4F2CYP4A11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040087633-A1 | Methylidene oxazolidinone compound and preparation method thereof | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2004-05-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040087633-A1 | Methylidene oxazolidinone compound and preparation method thereof | OXA1L, TET1, TET2 | MEN1 342/4885KMT2A 501/4885ALDH1A1 1232/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.